{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:02:06Z","timestamp":1793163726398,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"the National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["P01HL116263"],"award-info":[{"award-number":["P01HL116263"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This paper reviews the existing literature supporting a role for fatty acid ethanolamides including oleoylethanolamide and palmitoylethanolamide in regulating cholesterol and triglyceride metabolism and the mechanisms underlying these effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Deletion of various fatty acid ethanolamide biosynthesis genes in cellular models and small animal models have provided additional evidence that endogenous biosynthesis of fatty acid ethanolamides regulates cholesterol and triglyceride metabolism, while new clinical trials using oleoylethanolamide and palmitoylethanolamide support their therapeutic potential to normalize lipid levels in individuals with cardiometabolic disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Fatty acid ethanolamides are biosynthesized in the intestine, liver, and adipose tissue in response to metabolic stimuli like fasting and feeding. These fatty acid ethanolamides then act via receptors including PPAR\u03b1, GPR119, and GPR55 to regulate cholesterol and triglyceride levels and promote the resolution of inflammation, thereby protecting against cardiometabolic diseases including metabolic-dysfunction associated steatotic liver disease and atherosclerotic cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s11883-026-01417-z","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:21:11Z","timestamp":1777710071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Regulation of Cholesterol and Triglyceride Metabolism by Fatty acid Ethanolamides"],"prefix":"10.1007","volume":"28","author":[{"given":"Sean S.","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Fadaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"6860","key":"1417_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/35102582","volume":"414","author":"F Rodr\u00edguez de Fonseca","year":"2001","unstructured":"Rodr\u00edguez de Fonseca F, Navarro M, G\u00f3mez R, Escuredo L, Nava F, Fu J, et al. An anorexic lipid mediator regulated by feeding. Nature. 2001;414(6860):209\u201312.","journal-title":"Nature"},{"issue":"38","key":"1417_CR2","doi-asserted-by":"publisher","first-page":"31905","DOI":"10.1074\/jbc.M112.368712","volume":"287","author":"T Uyama","year":"2012","unstructured":"Uyama T, Ikematsu N, Inoue M, Shinohara N, Jin XH, Tsuboi K, et al. Generation of N-acylphosphatidylethanolamine by members of the phospholipase A\/acyltransferase (PLA\/AT) family. J Biol Chem. 2012;287(38):31905\u201319.","journal-title":"J Biol Chem"},{"issue":"9","key":"1417_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nchembio.2127","volume":"12","author":"Y Ogura","year":"2016","unstructured":"Ogura Y, Parsons WH, Kamat SS, Cravatt BF. A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines. Nat Chem Biol. 2016;12(9):669\u201371.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"1417_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41467-018-08051-7","volume":"10","author":"A Everard","year":"2019","unstructured":"Everard A, Plovier H, Rastelli M, Van Hul M, de Wouters d\u2019Oplinter A, Geurts L, et al. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. Nat Commun. 2019;10(1):457.","journal-title":"Nat Commun"},{"key":"1417_CR5","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1038\/ncomms7495","volume":"6","author":"L Geurts","year":"2015","unstructured":"Geurts L, Everard A, Van Hul M, Essaghir A, Duparc T, Matamoros S, et al. Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. Nat Commun. 2015;6:6495.","journal-title":"Nat Commun"},{"key":"1417_CR6","doi-asserted-by":"crossref","unstructured":"Lefort C, Roumain M, Van Hul M, Rastelli M, Manco R, Leclercq I et al. Hepatic NAPE-PLD Is a key regulator of liver lipid metabolism. Cells. 2020;9(5):1247.","DOI":"10.3390\/cells9051247"},{"issue":"15","key":"1417_CR7","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1021\/bi060163l","volume":"45","author":"D Leung","year":"2006","unstructured":"Leung D, Saghatelian A, Simon GM, Cravatt BF. Inactivation of N-Acyl Phosphatidylethanolamine Phospholipase D Reveals Multiple Mechanisms for the Biosynthesis of Endocannabinoids. Biochemistry. 2006;45(15):4720\u20136.","journal-title":"Biochemistry"},{"issue":"6","key":"1417_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbalip.2016.03.003","volume":"1861","author":"E Leishman","year":"2016","unstructured":"Leishman E, Mackie K, Luquet S, Bradshaw HB. Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain. Biochim Biophys Acta. 2016;1861(6):491\u2013500.","journal-title":"Biochim Biophys Acta"},{"issue":"36","key":"1417_CR9","doi-asserted-by":"publisher","first-page":"26465","DOI":"10.1074\/jbc.M604660200","volume":"281","author":"GM Simon","year":"2006","unstructured":"Simon GM, Cravatt BF. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha\/beta-hydrolase 4 in this pathway. J Biol Chem. 2006;281(36):26465\u201372.","journal-title":"J Biol Chem"},{"issue":"14","key":"1417_CR10","doi-asserted-by":"publisher","first-page":"9341","DOI":"10.1074\/jbc.M707807200","volume":"283","author":"GM Simon","year":"2008","unstructured":"Simon GM, Cravatt BF. Anandamide Biosynthesis Catalyzed by the Phosphodiesterase GDE1 and Detection of Glycerophospho-N-acyl Ethanolamine Precursors in Mouse Brain*. J Biol Chem. 2008;283(14):9341\u20139.","journal-title":"J Biol Chem"},{"issue":"36","key":"1417_CR11","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.1073\/pnas.0601832103","volume":"103","author":"J Liu","year":"2006","unstructured":"Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R, Gong Q, et al. A biosynthetic pathway for anandamide. Proc Natl Acad Sci. 2006;103(36):13345\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"1417_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbalip.2005.12.011","volume":"1761","author":"G Petersen","year":"2006","unstructured":"Petersen G, Sorensen C, Schmid PC, Artmann A, Tang-Christensen M, Hansen SH, et al. Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors. Biochim Biophys Acta. 2006;1761(2):143\u201350. discussion 1\u20132.","journal-title":"Biochim Biophys Acta"},{"issue":"48","key":"1417_CR13","doi-asserted-by":"publisher","first-page":"36569","DOI":"10.1074\/jbc.M606646200","volume":"281","author":"BQ Wei","year":"2006","unstructured":"Wei BQ, Mikkelsen TS, McKinney MK, Lander ES, Cravatt BF. A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals*. J Biol Chem. 2006;281(48):36569\u201378.","journal-title":"J Biol Chem"},{"issue":"8","key":"1417_CR14","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/cbdv.200790159","volume":"4","author":"K Tsuboi","year":"2007","unstructured":"Tsuboi K, Takezaki N, Ueda N. The N-acylethanolamine-hydrolyzing acid amidase (NAAA). Chem Biodivers. 2007;4(8):1914\u201325.","journal-title":"Chem Biodivers"},{"issue":"4","key":"1417_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1124\/mol.110.070201","volume":"79","author":"C Zhu","year":"2011","unstructured":"Zhu C, Solorzano C, Sahar S, Realini N, Fung E, Sassone-Corsi P, et al. Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages. Mol Pharmacol. 2011;79(4):786\u201392.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1417_CR16","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1074\/jbc.M607809200","volume":"282","author":"J Fu","year":"2007","unstructured":"Fu J, Astarita G, Gaetani S, Kim J, Cravatt BF, Mackie K, et al. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem. 2007;282(2):1518\u201328.","journal-title":"J Biol Chem"},{"issue":"5","key":"1417_CR17","doi-asserted-by":"publisher","first-page":"R1407","DOI":"10.1152\/ajpregu.00664.2005","volume":"290","author":"G Astarita","year":"2006","unstructured":"Astarita G, Rourke BC, Andersen JB, Fu J, Kim JH, Bennett AF, et al. Postprandial increase of oleoylethanolamide mobilization in small intestine of the Burmese python (Python molurus). Am J Physiol Regul Integr Comp Physiol. 2006;290(5):R1407\u201312.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"15","key":"1417_CR18","first-page":"2761","volume":"217","author":"AB Tinoco","year":"2014","unstructured":"Tinoco AB, Armirotti A, Isorna E, Delgado MJ, Piomelli D, de Pedro N. Role of oleoylethanolamide as a feeding regulator in goldfish. J Exp Biol. 2014;217(15):2761\u20139.","journal-title":"J Exp Biol"},{"key":"1417_CR19","doi-asserted-by":"publisher","first-page":"106869","DOI":"10.1016\/j.prostaglandins.2024.106869","volume":"174","author":"Z Mashhadi","year":"2024","unstructured":"Mashhadi Z, Yin L, Dosoky NS, Chen W, Davies SS. Plaat1l1 controls feeding induced NAPE biosynthesis and contributes to energy balance regulation in zebrafish. Prostaglandins Other Lipid Mediat. 2024;174:106869.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"4","key":"1417_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cmet.2008.08.005","volume":"8","author":"GJ Schwartz","year":"2008","unstructured":"Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, Campolongo P, et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metabol. 2008;8(4):281\u20138.","journal-title":"Cell Metabol"},{"issue":"31","key":"1417_CR21","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.1073\/pnas.1104675108","volume":"108","author":"NV DiPatrizio","year":"2011","unstructured":"DiPatrizio NV, Astarita G, Schwartz G, Li X, Piomelli D. Endocannabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci U S A. 2011;108(31):12904\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1417_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/oby.2009.186","volume":"18","author":"AA Izzo","year":"2010","unstructured":"Izzo AA, Piscitelli F, Capasso R, Marini P, Cristino L, Petrosino S, et al. Basal and fasting\/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. Obes (Silver Spring). 2010;18(1):55\u201362.","journal-title":"Obes (Silver Spring)"},{"issue":"6","key":"1417_CR23","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1074\/jbc.M606369200","volume":"282","author":"XH Jin","year":"2007","unstructured":"Jin XH, Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. Discovery and characterization of a Ca2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. J Biol Chem. 2007;282(6):3614\u201323.","journal-title":"J Biol Chem"},{"key":"1417_CR24","doi-asserted-by":"crossref","unstructured":"Seramur ME, Sink S, Cox AO, Furdui CM, Key C-CC. ABHD4 regulates adipocyte differentiation\u2009<\u2009em\u2009>\u2009in\u00a0vitro\u2009but does not affect adipose tissue lipid metabolism in mice. Journal of Lipid Research.2023;64(8).","DOI":"10.1016\/j.jlr.2023.100405"},{"issue":"27","key":"1417_CR25","doi-asserted-by":"publisher","first-page":"27849","DOI":"10.1074\/jbc.M404087200","volume":"279","author":"M Guzm\u00e1n","year":"2004","unstructured":"Guzm\u00e1n M, Lo Verme J, Fu J, Oveisi F, Bl\u00e1zquez C, Piomelli D. Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor \u03b1 (PPAR-\u03b1)*. J Biol Chem. 2004;279(27):27849\u201354.","journal-title":"J Biol Chem"},{"issue":"10","key":"1417_CR26","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jnutbio.2009.07.006","volume":"21","author":"C Thabuis","year":"2010","unstructured":"Thabuis C, Destaillats F, Landrier J-F, Tissot-Favre D, Martin J-C. Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice. J Nutr Biochem. 2010;21(10):922\u20138.","journal-title":"J Nutr Biochem"},{"issue":"8","key":"1417_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","volume":"48","author":"J Fu","year":"2005","unstructured":"Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology. 2005;48(8):1147\u201353.","journal-title":"Neuropharmacology"},{"issue":"3","key":"1417_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jphs.2014.12.001","volume":"127","author":"L Li","year":"2015","unstructured":"Li L, Li L, Chen L, Lin X, Xu Y, Ren J, et al. Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats. J Pharmacol Sci. 2015;127(3):244\u201350.","journal-title":"J Pharmacol Sci"},{"key":"1417_CR29","doi-asserted-by":"publisher","first-page":"177306","DOI":"10.1016\/j.ejphar.2025.177306","volume":"991","author":"MM El Tabaa","year":"2025","unstructured":"El Tabaa MM, Faheem H, Elballal MS, Rashad E, Mohsen M, El Tabaa MM. The PPAR-\u03b1 agonist oleoyethanolamide (OEA) ameliorates valproic acid-induced steatohepatitis in rats via suppressing Wnt3a\/\u03b2-catenin and activating PGC-1\u03b1: Involvement of network pharmacology and molecular docking. Eur J Pharmacol. 2025;991:177306.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1417_CR30","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1210\/en.2013-1823","volume":"155","author":"G Mattace Raso","year":"2014","unstructured":"Mattace Raso G, Santoro A, Russo R, Simeoli R, Paciello O, Di Carlo C, et al. Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats. Endocrinology. 2014;155(4):1291\u2013301.","journal-title":"Endocrinology"},{"issue":"1","key":"1417_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1096\/fj.201901510RR","volume":"34","author":"C Annunziata","year":"2020","unstructured":"Annunziata C, Lama A, Pirozzi C, Cavaliere G, Trinchese G, Di Guida F, et al. Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice. Faseb j. 2020;34(1):350\u201364.","journal-title":"Faseb j"},{"key":"1417_CR32","doi-asserted-by":"crossref","unstructured":"Tovar R, de Ceglia M, Ubaldi M, Rodr\u00edguez-Pozo M, Soverchia L, Cifani C et al. Administration of linoleoylethanolamide reduced weight gain, dyslipidemia, and inflammation associated with high-fat-diet-induced obesity. Nutrients. 2023;15(20):4448.","DOI":"10.3390\/nu15204448"},{"key":"1417_CR33","doi-asserted-by":"publisher","first-page":"5721167","DOI":"10.1155\/2022\/5721167","volume":"2022","author":"M Sabahi","year":"2022","unstructured":"Sabahi M, Ahmadi SA, Kazemi A, Mehrpooya M, Khazaei M, Ranjbar A, et al. The Effect of Oleoylethanolamide (OEA) Add-On Treatment on Inflammatory, Oxidative Stress, Lipid, and Biochemical Parameters in the Acute Ischemic Stroke Patients: Randomized Double-Blind Placebo-Controlled Study. Oxid Med Cell Longev. 2022;2022:5721167.","journal-title":"Oxid Med Cell Longev"},{"key":"1417_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clnesp.2023.10.013","volume":"58","author":"H Tutunchi","year":"2023","unstructured":"Tutunchi H, Ebrahimi-Mameghani M, Hosseinzadeh-Attar MJ, Roshanravan N, Mobasseri M, Najafipour F, et al. Effects of oleoylethanolamide supplementation on the expression of lipid metabolism-related genes and serum NRG4 levels in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Clin Nutr ESPEN. 2023;58:311\u20139.","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"1417_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12902-024-01738-7","volume":"24","author":"A Ostadrahimi","year":"2024","unstructured":"Ostadrahimi A, Khajebishak Y, Moradi F, Payahoo L. The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial. BMC Endocr Disord. 2024;24(1):210.","journal-title":"BMC Endocr Disord"},{"key":"1417_CR36","doi-asserted-by":"crossref","unstructured":"Batacan R Jr., Briskey D, Bajagai YS, Smith C, Stanley D, Rao A. Effect of palmitoylethanolamide compared to a placebo on the gut microbiome and biochemistry in an overweight adult population: A Randomised, placebo controlled, double-blind study. Biomedicines. 2024;12(7):1620.","DOI":"10.3390\/biomedicines12071620"},{"issue":"1","key":"1417_CR37","doi-asserted-by":"publisher","first-page":"e85337","DOI":"10.1371\/journal.pone.0085337","volume":"9","author":"A Fan","year":"2014","unstructured":"Fan A, Wu X, Wu H, Li L, Huang R, Zhu Y, et al. Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL. PLoS ONE. 2014;9(1):e85337.","journal-title":"PLoS ONE"},{"issue":"11","key":"1417_CR38","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/ATVBAHA.118.311185","volume":"38","author":"P Rinne","year":"2018","unstructured":"Rinne P, Guillamat-Prats R, Rami M, Bindila L, Ring L, Lyytik\u00e4inen LP, et al. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation. Arterioscler Thromb Vasc Biol. 2018;38(11):2562\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1417_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41598-018-37373-1","volume":"9","author":"LS May-Zhang","year":"2019","unstructured":"May-Zhang LS, Chen Z, Dosoky NS, Yancey PG, Boyd KL, Hasty AH, et al. Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor(-\/-) Mice Improves Indices of Cardiometabolic Disease. Sci Rep. 2019;9(1):420.","journal-title":"Sci Rep"},{"issue":"6953","key":"1417_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature01921","volume":"425","author":"J Fu","year":"2003","unstructured":"Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodr\u00edguez de Fonseca F, et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-\u03b1. Nature. 2003;425(6953):90\u20133.","journal-title":"Nature"},{"issue":"1","key":"1417_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1124\/mol.104.006353","volume":"67","author":"J Lo Verme","year":"2005","unstructured":"Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, et al. The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-\u03b1 Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide. Mol Pharmacol. 2005;67(1):15\u20139.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"1417_CR42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/sj.bjp.0707424","volume":"152","author":"I Matias","year":"2007","unstructured":"Matias I, Gonthier MP, Petrosino S, Docimo L, Capasso R, Hoareau L, et al. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Br J Pharmacol. 2007;152(5):676\u201390.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1417_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","volume":"3","author":"HA Overton","year":"2006","unstructured":"Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006;3(3):167\u201375.","journal-title":"Cell Metab"},{"issue":"24","key":"1417_CR44","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1111\/bph.12877","volume":"171","author":"MS Engelstoft","year":"2014","unstructured":"Engelstoft MS, Norn C, Hauge M, Holliday ND, Elster L, Lehmann J, et al. Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119. Br J Pharmacol. 2014;171(24):5774\u201389.","journal-title":"Br J Pharmacol"},{"key":"1417_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bcp.2016.08.018","volume":"119","author":"HA Hassing","year":"2016","unstructured":"Hassing HA, Fares S, Larsen O, Pad H, Hauge M, Jones RM, et al. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119. Biochem Pharmacol. 2016;119:66\u201375.","journal-title":"Biochem Pharmacol"},{"issue":"43","key":"1417_CR46","doi-asserted-by":"publisher","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","volume":"284","author":"A Kapur","year":"2009","unstructured":"Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS, et al. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem. 2009;284(43):29817\u201327.","journal-title":"J Biol Chem"},{"issue":"7","key":"1417_CR47","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1073\/pnas.0711278105","volume":"105","author":"JE Lauckner","year":"2008","unstructured":"Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A. 2008;105(7):2699\u2013704.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 10","key":"1417_CR48","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1242\/jcs.020958","volume":"121","author":"M Waldeck-Weiermair","year":"2008","unstructured":"Waldeck-Weiermair M, Zoratti C, Osibow K, Balenga N, Goessnitzer E, Waldhoer M, et al. Integrin clustering enables anandamide-induced Ca2\u2009+\u2009signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. J Cell Sci. 2008;121(Pt 10):1704\u201317.","journal-title":"J Cell Sci"},{"key":"1417_CR49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fnins.2017.00293","volume":"11","author":"M Koch","year":"2017","unstructured":"Koch M. Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review. Front Neurosci. 2017;11:293.","journal-title":"Front Neurosci"},{"issue":"7","key":"1417_CR50","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","volume":"152","author":"E Ryberg","year":"2007","unstructured":"Ryberg E, Larsson N, Sj\u00f6gren S, Hjorth S, Hermansson NO, Leonova J, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007;152(7):1092\u2013101.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1417_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors. Pharmacol Rev. 2002;54(2):161\u2013202.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"1417_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/med.20135","volume":"29","author":"LO Hanus","year":"2009","unstructured":"Hanus LO. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Med Res Rev. 2009;29(2):213\u201371.","journal-title":"Med Res Rev"},{"issue":"2","key":"1417_CR53","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1096\/fj.10-166595","volume":"25","author":"TA Diep","year":"2011","unstructured":"Diep TA, Madsen AN, Holst B, Kristiansen MM, Wellner N, Hansen SH, et al. Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J. 2011;25(2):765\u201374.","journal-title":"FASEB J"},{"issue":"13","key":"1417_CR54","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1096\/fj.03-1080fje","volume":"18","author":"S Terrazzino","year":"2004","unstructured":"Terrazzino S, Berto F, Dalle Carbonare M, Fabris M, Guiotto A, Bernardini D, et al. Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. FASEB J. 2004;18(13):1580\u20132.","journal-title":"FASEB J"},{"issue":"6","key":"1417_CR55","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1194\/jlr.C300008-JLR200","volume":"45","author":"MJ Nielsen","year":"2004","unstructured":"Nielsen MJ, Petersen G, Astrup A, Hansen HS. Food intake is inhibited by oral oleoylethanolamide. J Lipid Res. 2004;45(6):1027\u20139.","journal-title":"J Lipid Res"},{"issue":"24","key":"1417_CR56","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1523\/JNEUROSCI.0036-10.2010","volume":"30","author":"S Gaetani","year":"2010","unstructured":"Gaetani S, Fu J, Cassano T, Dipasquale P, Romano A, Righetti L, et al. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci. 2010;30(24):8096\u2013101.","journal-title":"J Neurosci"},{"key":"1417_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.phrs.2017.05.017","volume":"122","author":"A Romano","year":"2017","unstructured":"Romano A, Gallelli CA, Koczwara JB, Braegger FE, Vitalone A, Falchi M, et al. Role of the area postrema in the hypophagic effects of oleoylethanolamide. Pharmacol Res. 2017;122:20\u201334.","journal-title":"Pharmacol Res"},{"key":"1417_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.peptides.2013.08.006","volume":"49","author":"A Romano","year":"2013","unstructured":"Romano A, Cassano T, Tempesta B, Cianci S, Dipasquale P, Coccurello R, et al. The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons. Peptides. 2013;49:21\u20136.","journal-title":"Peptides"},{"issue":"10","key":"1417_CR59","doi-asserted-by":"publisher","first-page":"E1266","DOI":"10.1152\/ajpendo.00411.2013","volume":"305","author":"A Romano","year":"2013","unstructured":"Romano A, Potes CS, Tempesta B, Cassano T, Cuomo V, Lutz T, et al. Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide. Am J Physiol Endocrinol Metab. 2013;305(10):E1266\u201373.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"31","key":"1417_CR60","doi-asserted-by":"publisher","first-page":"11527","DOI":"10.1073\/pnas.1322016111","volume":"111","author":"G Provensi","year":"2014","unstructured":"Provensi G, Coccurello R, Umehara H, Munari L, Giacovazzo G, Galeotti N, et al. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake. Proc Natl Acad Sci U S A. 2014;111(31):11527\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1417_CR61","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2337\/db08-1237","volume":"58","author":"LM Lauffer","year":"2009","unstructured":"Lauffer LM, Iakoubov R, Brubaker PL. GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell. Diabetes. 2009;58(5):1058\u201366.","journal-title":"Diabetes"},{"issue":"4","key":"1417_CR62","doi-asserted-by":"publisher","first-page":"R595","DOI":"10.1152\/ajpregu.00459.2017","volume":"315","author":"JD Brown","year":"2018","unstructured":"Brown JD, McAnally D, Ayala JE, Burmeister MA, Morfa C, Smith L, et al. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice. Am J Physiol Regul Integr Comp Physiol. 2018;315(4):R595\u2013608.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"1417_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1677\/JOE-08-0453","volume":"201","author":"H Lan","year":"2009","unstructured":"Lan H, Vassileva G, Corona A, Liu L, Baker H, Golovko A, et al. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J Endocrinol. 2009;201(2):219\u201330.","journal-title":"J Endocrinol"},{"issue":"3","key":"1417_CR64","doi-asserted-by":"publisher","first-page":"R729","DOI":"10.1152\/ajpregu.00029.2005","volume":"289","author":"K Proulx","year":"2005","unstructured":"Proulx K, Cota D, Casta\u00f1eda TR, Tsch\u00f6p MH, D\u2019Alessio DA, Tso P, et al. Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity. Am J Physiol Regul Integr Comp Physiol. 2005;289(3):R729\u201337.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"1417_CR65","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne N, Weyers B, Desmet SJ, Deckers J, Ray DW, Staels B, et al. Molecular Actions of PPAR\u03b1 in Lipid Metabolism and Inflammation. Endocr Rev. 2018;39(5):760\u2013802.","journal-title":"Endocr Rev"},{"issue":"40","key":"1417_CR66","doi-asserted-by":"publisher","first-page":"25713","DOI":"10.1074\/jbc.273.40.25713","volume":"273","author":"N Vu-Dac","year":"1998","unstructured":"Vu-Dac N, Chopin-Delannoy S, Gervois P, Bonnelye E, Martin G, Fruchart JC, et al. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J Biol Chem. 1998;273(40):25713\u201320.","journal-title":"J Biol Chem"},{"issue":"11","key":"1417_CR67","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1172\/JCI18730","volume":"114","author":"AC Li","year":"2004","unstructured":"Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta\/delta, and gamma. J Clin Invest. 2004;114(11):1564\u201376.","journal-title":"J Clin Invest"},{"issue":"4","key":"1417_CR68","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1194\/jlr.M044669","volume":"55","author":"Y-W Hu","year":"2014","unstructured":"Hu Y-W, Yang J-Y, Ma X, Chen Z-P, Hu Y-R, Zhao J-Y, et al. A lincRNA-DYNLRB2-2\/GPR119\/GLP-1R\/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis. J Lipid Res. 2014;55(4):681\u201397.","journal-title":"J Lipid Res"},{"issue":"3","key":"1417_CR69","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/1440-1681.13423","volume":"48","author":"H Tadaki","year":"2021","unstructured":"Tadaki H, Ogawa N, Yamanaka M, Motohashi Y, Sasase T, Kawai T, et al. JTP-109192, a novel G protein-coupled receptor 119 agonist, prevents atherosclerosis by improving hypercholesterolaemia in congenic spontaneously hyperlipidaemic mice. Clin Exp Pharmacol Physiol. 2021;48(3):381\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1417_CR70","doi-asserted-by":"publisher","first-page":"R235","DOI":"10.1152\/ajpregu.00270.2006","volume":"292","author":"Y Yang","year":"2007","unstructured":"Yang Y, Chen M, Georgeson KE, Harmon CM. Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction. Am J Physiology-Regulatory Integr Comp Physiol. 2007;292(1):R235\u201341.","journal-title":"Am J Physiology-Regulatory Integr Comp Physiol"},{"issue":"12","key":"1417_CR71","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1194\/jlr.M089250","volume":"59","author":"X Pan","year":"2018","unstructured":"Pan X, Schwartz GJ, Hussain MM. Oleoylethanolamide differentially regulates glycerolipid synthesis and lipoprotein secretion in intestine and liver. J Lipid Res. 2018;59(12):2349\u201359.","journal-title":"J Lipid Res"},{"issue":"3","key":"1417_CR72","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1096\/fj.201801408R","volume":"33","author":"M Igarashi","year":"2019","unstructured":"Igarashi M, Watanabe K, Tsuduki T, Kimura I, Kubota N. NAPE-PLD controls OEA synthesis and fat absorption by regulating lipoprotein synthesis in an in vitro model of intestinal epithelial cells. Faseb j. 2019;33(3):3167\u201379.","journal-title":"Faseb j"},{"issue":"3","key":"1417_CR73","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/SLA.0000000000003093","volume":"271","author":"CR Hutch","year":"2020","unstructured":"Hutch CR, Trakimas DR, Roelofs K, Pressler J, Sorrell J, Cota D, et al. Oea Signaling Pathways and the Metabolic Benefits of Vertical Sleeve Gastrectomy. Ann Surg. 2020;271(3):509\u201318.","journal-title":"Ann Surg"},{"key":"1417_CR74","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.tice.2024.102476","volume":"90","author":"Q Lu","year":"2024","unstructured":"Lu Q, Chen X, Zhang Q. PGC1\u03b1 enhances macrophage efferocytosis in ox-LDL-stimulated RAW264.7 cells by regulating the NLRP3\/PPAR\u03b1 axis. Tissue Cell. 2024;90:102476.","journal-title":"Tissue Cell"},{"issue":"2","key":"1417_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20201340","volume":"135","author":"D Gu","year":"2021","unstructured":"Gu D, Fang D, Zhang M, Guo J, Ren H, Li X, et al. Gastrin, via activation of PPAR\u03b1, protects the kidney against hypertensive injury. Clin Sci (Lond). 2021;135(2):409\u201327.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1417_CR76","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/bab.2656","volume":"72","author":"W Jiang","year":"2025","unstructured":"Jiang W, Yu W, Tan Y. Activation of GPR55 alleviates neuropathic pain and chronic inflammation. Biotechnol Appl Biochem. 2025;72(1):196\u2013206.","journal-title":"Biotechnol Appl Biochem"},{"key":"1417_CR77","doi-asserted-by":"crossref","unstructured":"Son SE, Lee YJ, Shin YJ, Kim DH, Im DS. GPR55 Antagonist CID16020046 Attenuates Obesity-Induced Airway Inflammation by Suppressing Chronic Low-Grade Inflammation in the Lungs. Int J Mol Sci. 2024;25(13):7358.","DOI":"10.3390\/ijms25137358"},{"key":"1417_CR78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbi.2018.11.017","volume":"76","author":"JD Hill","year":"2019","unstructured":"Hill JD, Zuluaga-Ramirez V, Gajghate S, Winfield M, Sriram U, Rom S, et al. Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation. Brain Behav Immun. 2019;76:165\u201381.","journal-title":"Brain Behav Immun"},{"issue":"7","key":"1417_CR79","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2337\/db24-0370","volume":"74","author":"J Yoo","year":"2025","unstructured":"Yoo J, Jun JE, Jeong IK, Ahn KJ, Chung HY, Lee MS, et al. DA-1241, a GPR119 Agonist, Ameliorates Fatty Liver Through the Upregulation of TFEB-Mediated Autophagy. Diabetes. 2025;74(7):1107\u201320.","journal-title":"Diabetes"},{"key":"1417_CR80","doi-asserted-by":"publisher","first-page":"115345","DOI":"10.1016\/j.biopha.2023.115345","volume":"166","author":"SH Lee","year":"2023","unstructured":"Lee SH, Park H, Yang EK, Lee BR, Jung IH, Kim TH, et al. GPR119 activation by DA-1241 alleviates hepatic and systemic inflammation in MASH mice through inhibition of NF\u03baB signaling. Biomed Pharmacother. 2023;166:115345.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1417_CR81","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00795-018-0200-4","volume":"52","author":"UA Bahirat","year":"2019","unstructured":"Bahirat UA, Talwar R, Shenoy RR, Nemmani KVS, Goel RN. Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes. Med Mol Morphol. 2019;52(1):36\u201343.","journal-title":"Med Mol Morphol"},{"issue":"3","key":"1417_CR82","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-2999(96)00015-5","volume":"300","author":"S Mazzari","year":"1996","unstructured":"Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol. 1996;300(3):227\u201336.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"1417_CR83","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","volume":"92","author":"L Facci","year":"1995","unstructured":"Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A. 1995;92(8):3376\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1417_CR84","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/00000542-200312000-00024","volume":"99","author":"WP Farquhar-Smith","year":"2003","unstructured":"Farquhar-Smith WP, Rice AS. A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. Anesthesiology. 2003;99(6):1391\u2013401.","journal-title":"Anesthesiology"},{"issue":"1","key":"1417_CR85","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuropharm.2007.06.003","volume":"54","author":"LE Wise","year":"2008","unstructured":"Wise LE, Cannavacciulo R, Cravatt BF, Martin BF, Lichtman AH. Evaluation of fatty acid amides in the carrageenan-induced paw edema model. Neuropharmacology. 2008;54(1):181\u20138.","journal-title":"Neuropharmacology"},{"issue":"11","key":"1417_CR86","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/bph.13580","volume":"174","author":"S Petrosino","year":"2017","unstructured":"Petrosino S, Di Marzo V. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol. 2017;174(11):1349\u201365.","journal-title":"Br J Pharmacol"},{"key":"1417_CR87","doi-asserted-by":"publisher","first-page":"114660","DOI":"10.1016\/j.intimp.2025.114660","volume":"155","author":"JE Lee","year":"2025","unstructured":"Lee JE, Im DS. Oleoylethanolamide ameliorates collagen-induced rheumatoid arthritis via activation of GPR119. Int Immunopharmacol. 2025;155:114660.","journal-title":"Int Immunopharmacol"},{"key":"1417_CR88","doi-asserted-by":"publisher","first-page":"114258","DOI":"10.1016\/j.intimp.2025.114258","volume":"149","author":"JE Lee","year":"2025","unstructured":"Lee JE, Im DS. Oleoylethanolamide ameliorates allergic asthma and atopic dermatitis via activation of GPR119. Int Immunopharmacol. 2025;149:114258.","journal-title":"Int Immunopharmacol"},{"key":"1417_CR89","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang Y, Wang Q, Wu C, Du G, Yang L. Oleoylethanolamide protects against acute ischemic stroke by promoting ppAR\u03b1-mediated microglia\/macrophage M2 polarization. Pharmaceuticals (Basel). 2023;16(4):621.","DOI":"10.3390\/ph16040621"},{"issue":"2","key":"1417_CR90","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbrc.2020.01.103","volume":"524","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhuo R, Zhao Y, Yang L, Zhou Y, Cheng X, et al. Oleoylethanolamide stabilizes atherosclerotic plaque through regulating macrophage polarization via AMPK-PPAR\u03b1 pathway. Biochem Biophys Res Commun. 2020;524(2):308\u201316.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1417_CR91","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1021\/acschembio.3c00401","volume":"18","author":"JE Zarrow","year":"2023","unstructured":"Zarrow JE, Alli-Oluwafuyi AM, Youwakim CM, Kim K, Jenkins AN, Suero IC, et al. Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages. ACS Chem Biol. 2023;18(8):1891\u2013904.","journal-title":"ACS Chem Biol"},{"issue":"2","key":"1417_CR92","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2008.12.040","volume":"205","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Matias I, Lenglet S, Petrosino S, Burger F, Pelli G, et al. Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis. Atherosclerosis. 2009;205(2):433\u201341.","journal-title":"Atherosclerosis"},{"key":"1417_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2016.12.023","volume":"231","author":"A Quercioli","year":"2017","unstructured":"Quercioli A, Carbone F, Bonaventura A, Liberale L, Pataky Z, Thomas A, et al. Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function. Int J Cardiol. 2017;231:1\u20135.","journal-title":"Int J Cardiol"},{"key":"1417_CR94","doi-asserted-by":"crossref","unstructured":"Kimberly WT, O\u2019Sullivan JF, Nath AK, Keyes M, Shi X, Larson MG et al. Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. JCI Insight. 2017;2(9):e92989.","DOI":"10.1172\/jci.insight.92989"},{"issue":"5","key":"1417_CR95","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1210\/clinem\/dgad668","volume":"109","author":"X Di","year":"2024","unstructured":"Di X, Martinez-Tellez B, Krekels EHJ, Jurado-Fasoli L, Osuna-Prieto FJ, Ortiz-Alvarez L, et al. Higher Plasma Levels of Endocannabinoids and Analogues Correlate With a Worse Cardiometabolic Profile in Young Adults. J Clin Endocrinol Metab. 2024;109(5):1351\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1417_CR96","doi-asserted-by":"publisher","first-page":"e1821","DOI":"10.1210\/clinem\/dgae657","volume":"110","author":"D Dion","year":"2025","unstructured":"Dion D, Noll C, Fortin M, Haroune L, Saibi S, Sarret P, et al. Plasma Endocannabinoids Are Independently Associated With the Metabolic Function of White Adipose Tissue. J Clin Endocrinol Metab. 2025;110(6):e1821\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1417_CR97","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.811992","volume":"119","author":"K Sugamura","year":"2009","unstructured":"Sugamura K, Sugiyama S, Nozaki T, Matsuzawa Y, Izumiya Y, Miyata K, et al. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation. 2009;119(1):28\u201336.","journal-title":"Circulation"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-026-01417-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:02:37Z","timestamp":1777723357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-026-01417-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1417"],"URL":"https:\/\/doi.org\/10.1007\/s11883-026-01417-z","relation":{},"ISSN":["1534-6242"],"issn-type":[{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"44"}}